Epidemiology and clinical features of Huntington's disease in MENASA region: A systematic review and meta-analysis
- 3 July 2025
- journal article
- review article
- Published by SAGE Publications in Journal of Huntington's Disease
- Vol. 14 (4) , 319-330
Abstract
Background: Given the scarcity of comprehensive data on Huntington's disease in many Asian and African countries, it is more effective to focus on specific regions where there is a significant concentration of available data. Objective: This study decided to evaluate the epidemiology and features of Huntington's disease in countries of the Middle East, North Africa, and South Asia (MENASA) regions. Methods: In this meta-analysis, the limited maximum likelihood (REML) approach was applied to the estimated point prevalence mentioned in original studies of each MENASA country. Additionally, research on Huntington's disease characteristics in each nation was utilized to give a general picture of the disease's status in those nations. Results: The pooled point prevalence estimation of the prevalence studies was 8.64 per 100,000 (95% CI, −0.04–17.33; I 2 = 100%). Among 14 cohort and cross-sectional studies on individuals with Huntington's disease in the MENASA region, 5.61% of the patients had juvenile-onset Huntington's disease, and 2.3% had late-onset Huntington's disease. In addition, 68.58%, 17.82%, and 45.17% of the individuals were reported with motor symptoms at the onset, abnormal cognitive assessment scores, and degrees of psychological disturbance, respectively. The mean age at onset was 44.85 years, and the mean number of pathologic CAG repeats was 45.46. Conclusions: Notable differences in the frequency of symptoms of onset and pooled prevalence of HD in the MENASA region probably address a serious lack of sufficient information. The results would help clinicians and governments develop public health strategies, and further research could be conducted on these results.Keywords
This publication has 49 references indexed in Scilit:
- Epidemiology of Huntington's Disease in Latin America: A Systematic Review and Meta‐AnalysisMovement Disorders, 2024
- Gene therapy for selected neuromuscular and trinucleotide repeat disorders – An insight to subsume South Asia for multicenter clinical trialsIBRO Neuroscience Reports, 2023
- Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease: a study of linked Swedish National Registries (2002–2019)Journal of Neurology, 2022
- Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta‐AnalysisMovement Disorders, 2022
- Association between sex and Huntington’s disease: an updated review on symptomatology and prognosis of neurodegenerative disordersWiener Medizinische Wochenschrift, 2022
- Late-onset Huntington disease: An Italian cohortJournal of Clinical Neuroscience, 2021
- PND67 The Real-World Epidemiology and Treatment Patterns of Huntington's Disease in IsraelValue in Health, 2020
- Late-onset Huntington’s disease with 40–42 CAG expansionNeurological Sciences, 2019
- Molecular genetic analysis of trinucleotide repeat disorders (TRDs) in Indian population and application of repeat primed PCREuropean Journal of Medical Genetics, 2015
- The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysisMovement Disorders, 2012